Lynx Investment Advisory’s Sanofi SNY Stock Holding History

Lynx Investment Advisory’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-109	Closed	-$5.29K	–	672
2024 Q2	$5.29K	Buy	+109	New	+$5.26K	﹤0.01%	466

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lynx Investment Advisory's SNY Position: Q3 2024 in Review

Lynx Investment Advisory sold out of Sanofi (SNY) in Q3 2024, closing a stake of 109 shares — an estimated $5.29K sold.

Lynx Investment Advisory first reported a position in SNY in Q2 2024 and held it in 1 quarter. The position peaked at $5.29K in Q2 2024. 756 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

Lynx Investment Advisory reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
Lynx Investment Advisory sold 109 Sanofi shares in Q3 2024, an estimated $5.29K.
Lynx Investment Advisory first reported a position in Sanofi in Q2 2024 and held it in 1 quarter.
Lynx Investment Advisory's Sanofi position peaked at $5.29K in Q2 2024.
756 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Lynx Investment Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.